Rechon Life Science, Adents Partner
News Sep 16, 2016
Rechon Life Science AB has partnered with Adents to offer its customers a scalable track & trace solution that complements its pharmaceuticals production and packaging services. For Adents, the deal represents further geographical expansion of its widening global customer base, including its first foray into Scandinavia. In choosing Adents, Rechon addresses compliance with several looming serialization mandates, including the European Union Falsified Medicines Directive and the USA’s Drug Supply Chain Security Act.
Eventually, all track & trace applications will be interfaced with Rechon’s Enterprise Resource Planning (ERP) system. To meet its evolving needs, Rechon required a software solution that was flexible enough to change line configurations per client needs, able to generate and securely import/export unique serial numbers, and offered a workable pricing model. Just as importantly, Rechon sought to use its existing infrastructure to incorporate this serialization solution.
Rechon has close ties with ACT-Logimark, a Sweden-based printing equipment provider and systems integration specialist. The Adents serialization and aggregation suite of software enables companies to achieve traceability and documentation compliance easily, addressing both current and emerging regulations while also minimizing impact on production processes and productivity. An ideal “standardized software” approach, Adents unit identification and traceability software is extremely flexible, scalable, and quick to deploy as it does not require add-on hardware.
It also helps enrich marketing and eliminate counterfeiting. Rechon offers a comprehensive range of pharmaceutical services, including the preparation, filling, packaging and distribution of commercial products as well as Clinical Trial Supplies. The company’s cGMP contract pharmaceutical development services include process and analytical development; manufacturing, supplies and services for clinical trials; stability studies; storage and distribution and Qualified Person (QP) release services.
Maria Wingren, Manager Projects & Validation, said: “As a company that manufactures and packages pharmaceutical products for leading pharmaceutical companies around the world Rechon requires regulatory solutions that address a wide array of both customer and internal needs. In Adents Pharma Suite software, we believe we’ve found a easy to use, standardized solution that meets the complexities of current and future track & trace mandates – a flexible, scalable approach that works within our existing hardware and various, client-specific line configurations.”
According to Christophe Devins, CEO and Founding Partner of Adents: “Our partnership with Rechon is far more than a typical vendor-customer relationship. It establishes an ecosystem of system integrators capable of implementing serialization solutions expediently and on a grand scale. This deal also brings together a consortium of experts capable of addressing track & trace issues from a holistic view – the effective marriage of software, hardware and line integration.”
Algorithm Predicts Life Expectancy After Heart AttackNews
A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more personalized assessments of people who are awaiting heart transplants, which in turn could enable health care providers to make better use of limited life-saving resources and potentially reduce health care costs.
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.